October 2011 Issue
Process knowledge demands a very different approach to sampling.
Preformulation, formulation and stability testing are all embracing QbD.
Authors from Pfizer and Rockwell Automation propose a closed-control scheme for pharmaceutical PAT.
Revived interest in SPC only heightens the need for new data architecture models
Communities can partner with manufacturers, but they cant apply pressure.
Companies like Pfizer have reduced time and increased efficiency by putting Apple's most recent showstopper, the iPad, to use in manufacturing.
The demand for improvements in single use, disposable bioprocessing equipment have shot to the top of end-users wish list of better, more innovative products in 2011.
Before rushing to sources in emerging markets, do you have the right long-term strategy, partners, and resources for managing the partnership?
How Alkermes implemented Risk-MaPP to maximize operator and patient safety.
Operations, like natural systems, are drawn to chaos. Only energetic management can stop the slide.
Customer audits can elevate a relationship, improve product quality, and lower costs for both parties.
When equipment and processes challenge solvent recovery for small-volume streams, an atypical approach is needed, says Pfizers Frank Urbanski.